NHS Supply Chain intends to launch a National Framework Agreement for the provision of In-Vitro Diagnostic Devices, Point of Care Testing Products & Related Pathology Services, this will include: - Pathology Managed Services - Reagent Rental Agreements - Pathology Maintenance Services - Pathology Software - Pathology Outsourced Services (Referral Testing Services) - Core Laboratory Equipment, Instruments & Consumables, to cover all pathology disciplines such as but not limited to Biochemistry, Microbiology, Immunology, Cellular Pathology, Virology, Haematology, Genomics & Molecular Testing and Reproductive Sciences - Point of Care Testing - Specimen Collection - Specimen Storage

This Lot seeks Managed Service (MS) solutions that delivers end-to-end pathology and POCT outcomes (preanalytical > analytical > postanalytical) with assured quality, resilient capacity, and measurable operational/clinical impact, while enabling the expansion of diagnostics into Community Diagnostic Centres (CDCs) and neighbourhood/community settings consistent with the NHS 10 Year Plan’s shift hospital > community; analogue > digital; sickness > prevention.

This Lot seeks to enable the procurement of IT Solutions that include but are not limited to Software, Middleware, Artificial Intelligence (AI) platforms, that will offer support in: • Clinical laboratory workflows • Diagnostic processing & Reporting • Sample Tracking & Archiving Solutions • Data interoperability across systems • Long term sample archiving • Specimen analysis and management • Integration with laboratory hardware • Modernisation & Transformation solutions • Laboratory Monitoring Solutions

This Lot seeks solutions that deliver safe, reliable, efficient and interoperable diagnostic outcomes across all pathology disciplines, NHS Screening Programmes and diagnostic care settings. Solutions may support the delivery of diagnostic services within laboratory environments, point of care settings, community diagnostic services and home/self-testing pathways whilst maintaining appropriate clinical performance, quality assurance, governance, interoperability and patient safety requirements. Solutions offered may support including but not limited to: • Blood Sciences (Haematology, Coagulation, Clinical Chemistry, Immunoassay, Toxicology, Transfusion & Transplantation Support) • Cellular Pathology (Histology, Cytology, Immunohistochemistry, In Situ Hybridisation) • Microbiology, Virology & Serology • Transfusion & Transplantation Support • Genomics & Molecular Diagnostics • Digital Pathology & Imaging • Reproductive Sciences (Andrology & Fertility Diagnostics) • Specimen Collection • Specimen Storage • Supportive Laboratory Infrastructure (Autopsy/Mortuary, Workflow Tools) • Research and Development Products

Procurement Act 2023

Open procedure

The Authority intends to establish an eight (8) year Open Framework. This Tender Notice relates to the award of the first Framework under the Open Framework, which will have a term of two (2) years. The Authority estimates that the total value of purchases under the first two (2) year Framework will be approximately £318,228,000 excluding VAT. This value is approximate only and may vary depending on the requirements of the bodies purchasing under the Framework. The anticipated total value of purchases across the full eight (8) year Open Framework is approximately £2,545,824,000 excluding VAT. The values provided are for guidance only and do not constitute a guarantee of business to any successful Tenderer.

https://nhssupplychain.app.jaggaer.com/